Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

REGISTER for free or LOG IN to view this content

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Coronary

CAD Pharma

Presentation

AHA 2022

STEMI

Up Next

Presentation AHA 2022

Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial

Presenter: Michelle L. O’Donoghue

November 07, 2022

More slides +

Presentation TCT 2022

TAVR of Yesterday is not the TAVR fo the Future

Presenter: Nicolas Van Mieghem

September 18, 2022

Presentation TCT 2022

Valve Function Insights from Bench Testing

Presenter: Janarthanan Sathananthan

September 18, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.